Introduction:

Peptide therapeutics is extensively used in cancer treatment, followed by infectious treatment medications in metabolic disorders, infectious disease, and diabetes, among others. The joining of two or more amino acid monomers via amide bonds forms peptides. The size of a peptide is what separates it from a protein. Peptides are defined as compounds that include no more than 50 amino acids. Peptides work by attaching to particular cell surface receptors, acting as mimics of receptor ligands, and assisting on the cell membrane to treat disorders. Peptide therapeutics, due to their increased specificity, safety, tolerability and its ability to offer better efficiency results in various therapeutic treatments, are in greater demand.  Increasing incidence and prevalence cases of cancer and diabetes, combing with growing research and development (R&D) activities to develop novel treatment therapies based on peptide therapeutics in the market, is expected to show lucrative growth in near future. Peptide Therapeutics Market size accounted for US$ 36.76 billion in 2020 and is estimated to be US$ 66.18 billion by 2030 and is anticipated to register a CAGR of 6.10%.

Companies invest much in R&D

Due to the measures done by numerous firms to investigate the creation of novel medication candidates, the market is anticipated to experience profitable growth throughout the forecast period. Companies invest much in R&D to create novel pharmaceuticals that are more effective at treating the ailments they are targeting in order to maintain their position in the market. Over the past ten years, there have been a lot more clinical trials for these medications. Over the projection term, this is also anticipated to fuel growth. For instance, Amgen and Generate Biomedicines announced a research partnership agreement in January 2022 to investigate and develop protein therapies for its five clinical objectives across numerous therapeutic areas and delivery methods.

Additionally, according to the World Health Organization, chronic diseases including cancer, diabetes, and cardiovascular diseases are the main causes of morbidity and mortality worldwide (WHO).

lchronic disease rates have exploded, spreading across all regions and affecting people from all socioeconomic backgrounds. According to estimates, chronic diseases will account for 70% of all fatalities and 60% of the burden of disease worldwide in 2020. As a result, the market is expected to be driven by the rising prevalence of chronic diseases and the increased demand for efficient therapies. However, the market expansion is anticipated to be constrained by the uncertainty surrounding peptide therapies, the rising cost of drug development, and tight regulatory requirements for medication approval.

Peptide therapeutics market has been segmented on the basis of type, application, route of administration and region.

Type Insights

On the basis of type, the peptide therapeutics market is segmented into branded peptide therapeutics and generic peptide therapeutics.  

Application Insights

On the basis of application, the peptide therapeutics market is segmented into cancer, cardiovascular disease, metabolic disease, respiratory disease, infectious disease and others.

Route of Administration Insights

On the basis of Route of administration for peptide therapeutics market includes oral administration, parenteral administration and others.

Regional Insights:

Peptide Therapeutics Market size accounted for US$ 36.76 billion in 2020 and is estimated to be US$ 66.18 billion by 2030 and is anticipated to register a CAGR of 6.10%. On region the Peptide Therapeutics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America expected to hold major market share in peptide therapeutics market, owing to the increasing demand of peptide therapeutics in cancer and diabetes treatment medications in these region, and increasing engagement of key manufacturing players and government in research and development for peptide therapeutics.  The growing need for peptide therapies treatment methods, increased medical research and development, and other factors are anticipated to boost the markets for these products in Western and Eastern Europe. The market for peptide therapies in Latin America is anticipated to increase steadily. The market for peptide therapies in Asia Pacific is expected to grow at a rapid CAGR throughout the forecast period, making it a very promising market. This is brought on by a sizable patient base, rising healthcare costs, and a growing demand for novel and cutting-edge therapies. Compared to other regions, the MEA peptide therapeutics market is anticipated to grow a little more slowly, but it is anticipated to accelerate toward the end of the forecast period.

Report Scope:

Attribute	Details
Base year for estimation	2020
Forecast period	2020 – 2030
Market representation	Revenue in USD Million & CAGR from 2020 – 2030
Market Segmentation	By Type – Branded Peptide and Generic Peptide By Application– Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, and Others By Route of Administration– Oral Administration, Parenteral Administration and Others
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Recent Development:

• The developer of NURTEC ODT, an advanced dual-acting migraine medicine approved for both acute treatments and episodic migraine prevention in adults, Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. announced a new collaboration in May 2022.
• Bristol Myers Squibb and LOTTE Corporation announced in MAY 2022 that LOTTE had made the decision to purchase Bristol Myers Squibb's production facility in East Syracuse, New York. LOTTE's innovative biologics CDMO business in the United States will be housed in East Syracuse.

Peptide Therapeutics Market, By Region:

• North America
  • Canada
  • U.S.
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East & Africa

The leading players operating in the Peptide Therapeutics Market includes

• Sanofi S.A. is a French-based international healthcare corporation with its headquarters in Paris.
• Pfizer Inc. is a worldwide pharmaceutical and biotechnology company with its main office in Manhattan, New York City.
• AstraZeneca Plc is a worldwide pharmaceutical and biotechnology firm with British and Swedish roots. Its headquarters are located in England.
• GlaxoSmithKline Plc a British multinational pharmaceutical corporation with its headquarters in London, formerly known as GlaxoSmithKline plc.
• Abbott Laboratories is a worldwide American firm that manufactures medical equipment and provides healthcare, with its headquarters in Abbott Park, Illinois.
• Novartis AG is a Swiss-based healthcare organisation that offers solutions to meet the changing demands of patients around the world.
• Teva Pharmaceutical Limited is a large, international pharmaceutical firm based in Petah Tikva, Israel.
• F. Hoffmann-La Roche AG a multinational healthcare corporation based in Switzerland, Roche is more popularly known. It has two business segments: pharmaceuticals and diagnostics. Shares of Roche Holding AG, its holding company, are traded on the SIX Swiss Exchange.
• Eli Lilly and Company is a multinational American pharmaceutical corporation with its headquarters in Indianapolis, Indiana.
• Johnson & Johnson is an American firm established in 1886 that creates consumer packaged goods, pharmaceuticals, and medical equipment.

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Preview
   • Executive Summary
   • Key Findings—Global Market Segmentation
     • Key Questions this Study will Answer
     • Market Snippet, By Type
     • Market Snippet, By Application
     • Market Snippet, By Route of Administration
     • Market Snippet, By Region
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Market Segmentation, By Type, 2020 – 2030, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Branded Peptide
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
   • Generic Peptide
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
6. Market Segmentation, By Application , 2020 – 2030, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Cancer
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
   • Cardiovascular Disease
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
   • Metabolic Disease
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
   • Respiratory Disease
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
   • Infectious Disease
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
   • Others
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
7. Market Segmentation, By Route of Administration, 2020 – 2030, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Oral Administration
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
   • Parenteral Administration
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
   • Others
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
8. Global Market, By Region, 2020 – 2030, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Bn), By Type, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Route of Administration, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast (US$ Bn), By Type, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Route of Administration, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
       • UK
       • France
       • Germany
       • Russia
       • Italy
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast (US$ Bn), By Type, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Route of Administration, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
       • India
       • Japan
       • South Korea
       • China
       • Rest of Asia Pacific
   • Latin America
     • Market Size and Forecast (US$ Bn), By Type, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Route of Administration, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
       • Brazil
       • Mexico
       • Rest of Latin America
   • Middle East & Africa
     • Market Size and Forecast (US$ Bn), By Type, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Route of Administration, 2020 – 2030
     • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
       • GCC
       • Israel
       • South Africa
       • Rest of Middle East
9. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
10. Company Profiles

• Sanofi S.A.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Pfizer Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• AstraZeneca Plc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• GlaxoSmithKline Plc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• F. Hoffmann-La Roche AG (Roche AG)
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Eli Lilly and Company
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Johnson & Johnson
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Abbott Laboratories
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Novartis AG
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Teva Pharmaceutical Limited
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

The Last Word

• Future Impact
• About Us
• Contact